Mrs Martha Louise Adams, MA,CCC-SLP | |
2900 12th St N, Naples, FL 34103-4528 | |
(239) 261-2554 | |
(239) 261-4540 |
Full Name | Mrs Martha Louise Adams |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 2900 12th St N, Naples, Florida |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1073857520 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | SA11472 (Florida) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Martha Louise Adams, MA,CCC-SLP 2900 12th St N, Naples, FL 34103-4528 Ph: (239) 261-2554 | Mrs Martha Louise Adams, MA,CCC-SLP 2900 12th St N, Naples, FL 34103-4528 Ph: (239) 261-2554 |
News Archive
Over the last 40 years, HIV has shifted from a deadly and mysterious virus to one that can be controlled with daily drugs. But attempts to completely eliminate the virus from the bodies of people living with HIV, curing them for good, have failed.
Proteon Therapeutics, Inc., a privately held biopharmaceutical company developing novel, first-in-class pharmaceuticals to address the critical medical needs of patients with kidney and vascular diseases, today announced that its lead product, PRT-201, has received orphan drug designation in the European Union for the prevention of arteriovenous access dysfunction in hemodialysis patients.
Antidepressants are commonly prescribed for the treatment of depression, but many individuals do not experience symptom relief from treatment.
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today reported additional clinical results for its lead product candidate, the Sufentanil NanoTab PCA System for the treatment of moderate-to-severe acute pain in the hospital setting.
Regulus Therapeutics Inc., founded by Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), and Isis Pharmaceuticals, Inc. (Nasdaq: ISIS), announced today that the United States Patent and Trademark Office (USPTO) has allowed a patent application within the ‘Esau' patent family (US Application Serial No. 10/909,125).
› Verified 4 days ago
Vanesa Bedoya Baquero, M.S., C-F SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6734 Lone Oak Blvd, Naples, FL 34109 Phone: 239-597-0935 | |
Mrs. Janice Lindsey Sukay, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8735 Gleneagle Way, Naples, FL 34120 Phone: 610-999-1777 | |
Ms. Sally Penrose, Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 273 Johnnycake Dr, Naples, FL 34110 Phone: 239-273-6029 | |
Jenai Carroll, Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 7828 Gardner Dr Unit 102, Naples, FL 34109 Phone: 201-230-7831 | |
Mr. Eric Carl Wiesner, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3490 Ocean Bluff Ct, Naples, FL 34120 Phone: 239-455-5705 | |
Darcia Marie Brawley, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 151 Cypress Way E Apt D107, Naples, FL 34110 Phone: 754-816-0627 | |
Mrs. Lauren Ashley Biddison, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2330 Immokalee Rd, Suite 2, Naples, FL 34110 Phone: 239-596-0831 Fax: 239-596-2155 |